New approach on the use of big data in clinical decision support

A new computational approach that allows the identification of molecular alterations associated with prognosis and resistance to therapy of different types of cancer was developed by the research grould led by Nuno Barbosa Morais, Group Leader at Instituto de Medicina Molecular João Lobo Antunes (iMM; Portugal), and now published open access in Nucleic Acids Research.

Top News

Ain't No God; don't even think about theism

UnFox News: not a propaganda arm of the Republican party